ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
28.786
0.00
(0.00%)
終了 2月5日 6:00AM
28.83
0.044
(0.15%)
取引時間後: 9:59AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
28.786
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
26.43 52 週間の範囲 30.67
時価総額
前日終値
28.786
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
3,827
発行済株式数
360,000
配当利回り
-
PER
5.51
1 株当たり利益 (EPS)
5.23
歳入
626k
純利益
1.88M

ProShares Global Listed Private Equity について

The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combin... The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combination, should track the performance of the index. It will invest at least 80% of its total assets in component securities. The fund will concentrate its investments in a particular industry or group of industries, country or region to approximately the same extent as the index is so concentrated. It is non-diversified. 詳細を表示

セクター
Mgmt Invt Offices, Open-end
業界
Mgmt Invt Offices, Open-end
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
ProShares Global Listed Private Equity is listed in the Mgmt Invt Offices, Open-end sector of the アメリカ証券取引所 with ticker PEX. The last closing price for ProShares Global Listed ... was US$28.79. Over the last year, ProShares Global Listed ... shares have traded in a share price range of US$ 26.43 to US$ 30.67.

ProShares Global Listed ... currently has 360,000 shares in issue. The market capitalisation of ProShares Global Listed ... is US$10.36 million. ProShares Global Listed ... has a price to earnings ratio (PE ratio) of 5.51.

PEX 最新ニュース

Apex Bioventures Acquisition Corp. Announces Stockholder Approval to Liquidate and Dissolve

HILLSBOROUGH, Calif., June 2 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced that at a special meeting of stockholders held today...

Apex Bioventures Acquisition Corporation Receives Notice of Extension from NYSE Amex

HILLSBOROUGH, Calif., May 11 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced today that it has received notice from NYSE Amex LLC...

Apex Bioventures Acquisition Corp. Sets Date for Special Meeting of Stockholders to Approve Dissolution

HILLSBOROUGH, Calif., May 7 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) ("Apex") announced today that a special meeting of stockholders will be held at...

Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve

HILLSBOROUGH, Calif., March 5 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) ("Apex") announced today that its board of directors has determined that...

Apex Receives Non-Compliance Letter from NYSE Alternext US

HILLSBOROUGH, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) announced today that it has received notice from NYSE Alternext US LLC...

Apex Bioventures Acquisition Corporation Signs Letter of Intent for Business Combination

HILLSBOROUGH, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (AMEX:PEX) announced today that, on December 13, 2008, it entered into a letter of intent with a...

Apex Bioventures Announces Trust Investment Details

HILLSBOROUGH, Calif., Oct. 14 /PRNewswire-FirstCall/ -- In light of recent events impacting the global financial markets, Apex Bioventures Acquisition Corp. (AMEX:PEX), a publicly traded special...

Apex Bioventures and Dynogen Pharmaceuticals Mutually Terminate Merger Agreement

Apex Bioventures Acquisition Corp. (AMEX: PEX), a publicly traded special purpose acquisition company with healthcare industry expertise, announced today its mutual agreement...

Apex Bioventures and Dynogen Pharmaceuticals Announce Definitive Merger Agreement

Apex Bioventures Acquisition Corp. (AMEX: PEX), a publicly traded special purpose acquisition company with healthcare industry expertise, and Dynogen Pharmaceuticals, Inc., a...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.2260.79131652661128.5628.9828.43341928.72005961SP
40.8062.8806290207327.9828.9827.2400228.07384802SP
120.3261.1454673225628.4629.2527.2382728.22704822SP
262.3568.9141127506626.4329.6226.43305328.30487356SP
520.5862.078014184428.230.6726.43303728.81460428SP
156-4.974-14.733412322333.7634.54523.03314828.59571588SP
260-5.7186-16.573442381634.504639.011517.49285429.54170685SP

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CAPTCaptiVision Inc
US$ 1.024
(133.26%)
246M
QNTMQuantum Biopharma Ltd
US$ 6.70
(110.69%)
78.56M
LTRYLottery com Inc
US$ 0.58
(85.90%)
129.21M
CPIXCumberland Pharmaceutical Inc
US$ 3.7801
(77.47%)
18.49M
INKTMiNK Therapeutics Inc
US$ 12.08
(53.69%)
350.86k
OMGAOmega Therapeutics Inc
US$ 0.1473
(-69.25%)
11.71M
VIRXViracta Therapeutics Inc
US$ 0.0352
(-54.76%)
6.33M
CYNCYNGN Inc
US$ 0.0708
(-39.44%)
137.42M
UPCUniverse Pharmaceuticals Inc
US$ 0.2663
(-36.20%)
1.9M
CSAICloudastructure Inc
US$ 12.98
(-31.68%)
57.03k
NVDANVIDIA Corporation
US$ 118.65
(1.71%)
256.77M
CAPTCaptiVision Inc
US$ 1.024
(133.26%)
246M
PLTRPalantir Technologies Inc
US$ 103.83
(23.99%)
230.5M
RGTIRigetti Computing Inc
US$ 13.71
(1.78%)
159.64M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.1518
(-22.11%)
142.77M

PEX Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock